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A B S T R A C T
Dexamethasone (DXM) is a synthetic adrenal corticosteroid with anti-inflammatory properties used for ther-
apeutic purposes in a wide range of pathologies and of the most common corticosteroids used for anabolic
purposes in beef cattle. It is proven that DXM induces histological changes, traceable as increasing fatty in-
filtration of the thymus associated with a concurrent decrease of the cortex-medulla ratio, so the histological
examination of the thymus gland has been established as an indirect morphological biomarker. The aim of the
present study is to compare thymus histology and DXM concentrations in biological fluids collected at slaugh-
terhouse after 1 month of DXM treatment. Our findings demonstrate that a low dosage of DXM administered to
12 months-old-Chianina beef cattle induces severe thymic atrophy with concurrent reduction of the cortex/
medulla ratio, demonstrable even when DXM residues are not found in serum and urine samples. It is worth to
note that, at the slaughterhouse, DXM residues are detectable in bile samples, indicating the ability of this
biological fluid to bio-concentrate the administered drug if compared to serum and urine. Therefore, bile could
be candidates as new liquid matrix for the screening programs planned to contrast the illegal use of anabolic
substances.
1. Introduction
The illicit use in long-term low-dose administration of
Dexamethasone (DXM) has been described to improve beef tenderness
and increase live weight via water retention[1]. European regulations
[2] banned the administration of growth promoters, including corti-
costeroids, allowing their use only for therapeutic purposes. However
their administration continues illicitly[1]. For all these reasons, max-
imum residue limits[3] have been fixed in various matrices to ensure
consumer safety and adequate withdrawal times have been established
for each authorized molecule. As part of this legislative framework,
routine monitoring is compulsory within Member States[1] and the
national program for residue surveillance (NRP), based on risk analysis
and local productions features, is drawn up every year by EU countries.
The detection of drug residues in biological samples is generally com-
plex. At present, the “gold standard” technique for the targeted ap-
proaches used in official control analysis is liquid chromatography
coupled to tandem mass spectrometry (LC-MS/MS), which can detect
directly the drug substance or its metabolites. However, considering the
low concentrations used for illicit treatments, the large number of
molecules potentially used (alone or in cocktail) and their rapid me-
tabolism and excretion, these compounds cannot be easily and con-
sistently detected by targeted chemical methods (LC-MS/MS)[4,5]. Bile
has been proved to act as bio-accumulator of administered drugs (and/
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or their metabolites) for a longer period than the “traditional” ones[6].
Indeed, Moretti et al.[7] recently validated a method for DXM and its
metabolites detection in bile samples within a more complex multi-
screening analyses aiming at improving the screening activities carried
out in NRP. The plan is nowadays well settled, but more data are
needed to better define differences among cattle breed, especially
considering the autochthonous slow-growing ones often reared in rural
areas. Chianina is an ancient Italian cattle breed, raised in Central Italy
for over twenty-two centuries, appreciated for its extremely large size
(bulls stand up to 1,700 kg and 1.8 m), but rarely cited in international
literature [8,9]. Chianina plays an important role in the Italian meat
industry: worldwide it’s a recognized producer of top quality beef,
specifically the famous “Florentine steak”, and has also been accredited
with the Protected Geographical Indication “White Bullock of the
Central Appenines”[8]. According to its slow-growing parameters,
Chianina bullocks can be slaughtered between 12 and 24 months.
The aim of the present study is to compare DXM concentrations in
different fluid samples from Chianina bullock at slaughterhouse to
provide new tools for illicit treatment detection including bile as new
matrix for chemical analyses, applying a method previously developed
and validated by the same chemical team[7] and support the recorded




A total of sixteen 12-months-old-males-Chianina beef cattle were
randomly divided in two groups of eight animals each, homogenous for
body weight and age, and farmed in the same conditions in two sepa-
rated boxes (10 × 15 m). Free access to water and feed (silage, soy,
maize, straw and mineral supplements) was guaranteed throughout the
study. Clinical examinations were performed daily by a veterinarian to
monitor animal health status and welfare. After a month of acclimati-
zation, the treated group (n = 8) received 0.7 mg of DXM (RAPISON®,
Fatro S. p. A. Ozzano Emilia, Bologna, Italy) once a day for 28 days,
while the control group (n = 8) received a placebo (the same compo-
sition except DXM). All animals were treated orally each morning,
during feed distribution. During the period spent at the farm, all ani-
mals resulted healthy and none received any antimicrobial treatment.
At day 0, 7, 14, 21, 28 and 33 urine and serum were sampled and stored
at −20 °C up to analysis.
Cattle were all slaughtered on day 33 (14 months of age), five days
after the last drug administration. At the slaughterhouse, accurate ante
mortem and post mortem inspections were conducted and serum, urine,
bile and thymus were collected. Bile samples were taken after gall-
bladder removal and immediately stored at −20 °C. Three bile samples
of the treated groups were unfortunately lost during the slaughtering
procedure. The experiment was authorized by the Italian Ministry of
Health (number 775/2015-P) and carried out according to European
Council Directive n.63/2010 adopted by Italian Government (D.lsg n.
26/2014). The carcasses of the treated animals were destroyed in ac-
cordance with European Council Directive 2003/74/EC.
2.2. Chemical analysis
2.2.1. Materials and reagents
Desametasone (DXM) was purchased from Sigma-Aldrich (Saint
Louis, MO, USA) and DXM-d4 was purchased from CDN Isotopes
(Pointe-Claire, Quebec, Canada). LC-MS grade acetonitrile, acetic acid,
hydrochloric acid, ethylacetate, methanol and sodium acetate were
supplied by Sigma-Aldrich, as well as β-glucuronidase (Helix pomatia
Type H-2 - code G0876). SPE OASIS HLB cartridges (60 mg/3mL) were
purchased from Waters Corporation (Milford, MA, USA), while NH2
cartridges (100 mg/6mL) from Biotage (Uppsala, Sweden).SPE Strata-
X-C 33u (200 mg, 6 mL) were from Phenomenex (Torrance, CA, USA).
2.2.2. Sample treatment
Urine and serum sample treatments were developed on the basis of
the protocols described by Biancotto et al.[10]and McWhinney et al.
[14], respectively, bringing some modifications. Briefly, 1.5 mL of urine
were added with internal standard (DXM-d4) and 10.5 mL of acetate
buffer (pH = 5.0). After enzymatic hydrolysis, 6 mL of sample were
purified through OASIS HLB and NH2 cartridges. After elution, the
dried residue was re-suspended in 500 µL of a mixture acetonitrile/
water/acetic acid (25:75:0.1 v:v:v) and injected in the LC system. After
the addition of internal standard, the serum sample (300 µL) was
treated with 500 µL of a solution 0.1 M of HCl and after about 30 min,
1 mL of water was added[11]. The centrifuged supernatant was then
purified by OASIS HLB and NH2 cartridges. The dried residue was re-
suspended in 200 µL and injected. Finally bile samples were prepared
following exactly the procedure conceived by Moretti et al.[7] for the
multiclass screening of fifty-three veterinary drugs among which DXM.
2.2.3. LC-MS/MS conditions
The determination of DXM was performed by liquid chromato-
graphy (Ultimate 3000 - Thermo Scientific, Waltham, MA, USA) cou-
pled to a quadrupole-orbitrap hybrid mass analyzer (Q-Exactive,
Thermo Scientific). For urine and serum samples, chromatographic
separation was achieved on a Kinetex XB - C18 analytical column
(100 × 3.0 mm, 2.6 μm, Phenomenex, Torrance, CA, USA) connected
to a guard cartridge (Gemini C18, 4 × 2.0 mm, Phenomenex). The
mobile phase was composed by (A) water with 0.1% acetic acid and (B)
acetonitrile with 0.1% acetic acid. Elution was accomplished with the
following solvents gradient: 0–0.5 min 0% B, 30% B at 10.5 min and
kept unchanged until 13 min, 95% B at 20 min and kept unchanged
until 24 min. Finally, the system returned to 0% B in 0.5 min and was
re-equilibrated for 3.5 min. The flow rate and the injection volume were
0.4 mL/min and 10 μL, respectively. The acquisition was carried out in
positive ionization mode (ESI + ). The ESI temperature was set at
350 °C, the capillary temperature at 300 °C and the electrospray voltage
at 3.5 kV. Sheath and auxiliary gas were 50 and 15 arbitrary units,
respectively. The acquisition was performed in full scan/ddMS2 mode.
The parameters were optimized as follows: i) full scan acquisition: re-
solution 70,000 FWHM (at m/z 200), AGC target 1.0 × 106 and in-
jection time = 300 ms; ii) dd-MS2: 17,500 FWHM (at m/z 200), AGC
target 5 × 105 and injection time = 80 ms. The Normalised Collision
Energy (NCE) was set at 10. The precursor ion ([M + H]±) was m/z
393.2066 and the fragment ions m/z 373.2000 and m/z 355.1896. Both
procedures were successfully validated according to Commission
Decision 2002/657/EC [12]. For bile samples the separation was
achieved on a Kinetex XB C18 (100 × 3 mm, 2.6 µm, 100 Å, Phe-
nomenex, Torrance, CA, USA) following the instrumental conditions
detailed in Moretti et al. [9].
2.3. Thymus histology and morphometry
At the slaughterhouse the central area of the thoracic portion of the
thymus was sampled, fixed in 10% neutral buffered formalin and par-
affin-embedded with standard procedures. Four µm thick sections were
stained with Haematoxylin and Eosin (H&E) for histological and mor-
phometrical investigations. In order to evaluate DXM-related thymus
atrophy, evidenced by adipose tissue infiltration of the parenchyma, the
scoring system adopted by the Italian histological monitoring plan
(histological NRP) was attributed. In detail, the amount of the assess-
ment of fat infiltration, as indirect marker of thymus atrophy, was
evaluated by light microscopy at low magnification (1x and 4x). This
scoring system classifies the degrees of atrophy into 3 grade: grade 1 is
attributed to minimal invasion of adipose tissue localized within the
thymus septa; grade 2 is attributed to moderate invasion of adipose
tissue in septa with minimal invasion of the cortex and grade 3,
M. Sebastianelli, et al. Steroids 160 (2020) 108671
2
ascribed to severe invasion of adipose tissue in the cortex with invasion
of the medullar part. The histological examination was blindly per-
formed by three independent observers. Interlaboratory concordance
tests followed by K of Cohen test (IC 95%) was applied to evaluate the
reproducibility of the diagnosis.
Morphometrical evaluation was performed at low magnification
(5x) with the microscope Eclipse Ci-L (Nikon Corporation, Japan) using
NIS-Elements Br-2 as software. For each slide, 5 functional lobules were
randomly selected to evaluate cortex and medulla thickness and the
cortex:medulla ratios (C/M) were calculated as reported by Bozzetta
et al. [16] and Vascellari et al. [17]. Briefly, a graduated line was used
to measure the extension of the lobule, starting and ending at the in-
terlobular connective or adipose tissue. A parallel line was drawn to
measure medulla thickness. The software converted the length of the
lines into µm. The cortex thickness was obtained by subtracting the
medulla thickness value from the first one and the cortex/medulla ratio
(C/M) was calculated.
2.4. Statistical analysis
Data obtained and distributed in a normal way were analysed by
ANOVA using the GLM procedure with the JMP-SAS software (2001),
including the groups as fixed factor. Data in the results were reported as
a quadratic mean ± mean standard error. The data distributed in a
non-normal way were categorized by Kruskal-Wallis rank sum test
using R software (R Development Core Team, 2013). Differences were
determined by Unpaired t test or Tukey test and considered significant
when p < 0.05.
3. Results and discussion
In vivo analyses revealed no DXM residues in the samples belonging
to the control group. In the sera collected from treated animals, DXM
residues were detected at 0.2 µg L-1 at the 28th day of treatment in 2 out
of 8 of the analyzed samples. In the urine samples, DXM was detected
during the overall treatment period, with maximum levels generally
reached at the 14th day with a detection rate of 100%. The fluctuation
trends of DXM residues in serum and urine samples observed in animals
from the 1th day of administration to the slaughterhouse indicate high
variability, which has to be taken into consideration within the
National Residue Plan regulation. These data are in discordance with
the findings of a previously published study[13] evaluating DXM urine
excretion during the drug administration period and after the end of the
treatment in beef cattle treated with low-dose of DXM.
At the slaughterhouse (5 days after the last administration), DXM
residues were detected neither in serum nor in urine (Table 1), but it is
worth to note that DXM was found in all the bile samples (five) be-
longing to the animals of the treated group, with estimated con-
centrations in the range of 1–3 µg L-1. Obtained data confirm the main
hypothesis that bile can be a valid matrix for detection of treatment at
Table 1
Chemical and histological analyses at slaughter expressed by single bullock.
GROUP ANIMAL ID ANALYSES AT SLAUGHTER
Chemical Analyses Histological Analyses
SERUMa(ng mL−1) URINEa(ng mL−1) BILEa (ng mL−1) Thymus Atrophy Score C/M ratio
CONTROL GROUP 1 < CCα < CCα < CCα Grade 1 3.022
2 < CCα < CCα < CCα Grade 1 2.672
3 < CCα < CCα < CCα Grade 1 3.406
4 < CCα < CCα < CCα Grade 1 3.56
5 < CCα < CCα < CCα Grade 1 2.086
6 < CCα < CCα < CCα Grade 1 2.594
7 < CCα < CCα < CCα Grade 1 3.426
8 < CCα < CCα < CCα Grade 1 2.422
TREATED GROUP 1 < CCα < CCα N/A Grade 3 0.570
2 < CCα < CCα 2 Grade 3 0.752
3 < CCα < CCα 1 Grade 3 1.252
4 < CCα < CCα 1 Grade 3 0.346
5 < CCα < CCα 2 Grade 3 0.862
6 < CCα < CCα 3 Grade 3 0.382
7 < CCα < CCα N/A Grade 3 0.388
8 < CCα < CCα N/A Grade 3 0.414
N/A: not analysed.
C/M ratio: Cortex/medulla ratio in Thymus.
CCα: limit of decision.
CCβ: detection capability.
a The DXM concentrations were calculated using the isotopic dilution methodology.
Fig. 1. (a) Slight physiological thymus atrophy due
to mild infiltration of adipose tissue at the periphery
of the lobules (score 1). (b) Severe adipose infiltra-
tion of the parenchyma and marked cortex atrophy
that reduced the medullary framework, up to the
complete replacement of the lymphoid tissue by fat
(score 3). (H&E – Bars 200 µm).
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slaughterhouse level. To support these findings, histological analyses
have been conducted including both the routine analysis of atrophy
score and a more accurate investigation of cortex/medulla ratio.
All thymus samples belonging to the control group showed mild
thymic atrophy (score 1), while in all thymus glands from the treated
group a severe adipose tissue infiltration with a severe cortex atrophy of
the parenchyma (score 3) was detected (Fig. 1). The thymus scores’
distributions resulted significantly different between groups
(p < 0.0001). The inter-laboratory agreement was confirmed by K
Cohen test with K value = 1 (95% confidence interval) resulting in an
optimal concordance according to the Altman scale. Cortex/medulla
ratio (C/M) data are shown in Fig. 2 and resulted different
(p < 0.0001) between groups.
Severe thymus atrophy evidenced in the study confirm the validity
of histological examination adopted in Italy within an official mon-
itoring plan in order to identify farms at major risk of illicit treatment. It
offers the advantage of detecting illicit treatments in a short time and at
low cost through the effects that anabolic substances determine on
target organs (thymus)[13–16] when urine residues are no more de-
tectable. Indeed, results obtained with morphometry confirmed the
findings of previous studies, indicating that the C/M ratio was reversed
in the treated animals in comparison to the physiological 2:1 ratio[15]
improving the approach to tackle the misuse of glucocorticoids in
cattle. This is strongly associated with corticosteroids treatment, with
an average value for treated group of 0.62. This value is slightly higher
than that of Charolaise bulls aged 19–21 months treated with 0.75 mg/
day DXM orally administered for 42 days, resulting in a C/M ratio of
0.53[16]. We believe that this small difference may be due not only to
the older age of the Charolaise bulls, but mostly to the adoption of a
DXM treatment protocol 12 days longer than ours, to the different
suspension period and to the use of a slightly higher daily dosage. Our
finding confirm that the C/M ratio can be examined as a simple and
objective parameter, useful for the detection of illegal treatment with
low doses of DXM, which could be applied independently from the
thymus score[15,16] and could support chemical analyses.
4. Conclusions
Thymus atrophy and relating cortex:medulla ratio decreases with
DXM treatment, which makes it potentially useful as a quantitative
indirect marker for the screening histological assay. Furthermore, the
methods developed for the chemical determinations of the molecules of
interest in the trial presented are suitable for the purpose. DXM urinary
excretion was no longer detected in slaughtered subjects 5 days after
treatment suspension and these results confirm the high and rapid rate
of urinary excretion of DXM, which could represent a weakness in
monitoring plans all over Europe. Finally, considering that bile is able
to bio-concentrate steroid metabolites, it can be strongly supported as
complementary matrix for the improvement of the detection capacity of
illicit use of DXM in cattle, since it increases the detection window in
comparison to the traditional liquid matrices like serum and urine.
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